Novel insight into the phenotype of microcephaly 19 in the patient with missense COPB2 mutation

• Published in: European journal of medical genetics 2023-10, Vol.66 (10), p.104846-104846, Article 104846
• Main Authors: Shiri, Amirmasoud, Jafari Khamirani, Hossein, Kamal, Neda, manoochehri, Jamal, Dianatpour, Mehdi, Tabei, Seyed Mohammad Bagher, Dastgheib, Seyed Alireza
• Format: Article
• Language: English
• Subjects: COPB2; Global developmental delay; Intellectual disability; MCPH19; Microcephaly; Seizures
• ISSN: 1769-7212; 1878-0849
• DOI: 10.1016/j.ejmg.2023.104846

COPB2 gene encodes the Coatomer Protein Complex Subunit Beta-2 that plays a crucial role in the cellular vesicle transport system and it is essential for brain development during embryogenesis. Mutations in COPB2 lead to an extremely rare genetic disease named Microcephaly type 19 with autosomal recessive inheritance. This study describes a missense pathogenic homozygous variant (NM_004766.3:c.760 C > T, p.Arg254Cys) in the COPB2 gene, which was identified by Whole-Exome sequencing and confirmed by Sanger sequencing. The proband of the present study is an eight-and-a-half-year-old Iranian female who was born to consanguineous parents. She manifests global developmental delay, intellectual disability, microcephaly, seizures, spasticity, strabismus, and failure to thrive symptoms. Moreover, she is unable to stand, walk, or speak. Here we report the second homozygous mutation (NM_004766.3:c.760 C > T, p.Arg254Cys) in the COPB2 gene in the second family in the world with MCPH19. The responsible variant (NM_004766.3:c.760 C > T, p.Arg254Cys) for the observed symptoms in the proband was identical to the identified variant in the previously reported Caucasian/Native American family. Sharing this extremely rare pathogenic variant in two families with different origins is an extraordinary event that could aid us to determine the phenotype of this disease more precisely. Eventually, we provide a case-based review of the clinical features and compared our findings to the previously reported family for a better understanding of the clinical presentation of Microcephaly type 19 disease.